Condition
Healthy Female Volunteer
Total Trials
4
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Completed3
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07431203CompletedPrimary
Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging
NCT07192328Not ApplicableCompleted
Dose-Efficacy of rTMS in Healthy Young Female Volunteers
NCT06917898Phase 1Active Not RecruitingPrimary
Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia
NCT05226338Phase 1CompletedPrimary
Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects
Showing all 4 trials